We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
O-4: Amiloride reduces stroke and renal injury in stroke-prone hypertensive rats.
- Authors
Sepehrdad, Reza; Oruene, Alafuro; Chander, Praveen N.; Stier, Jr, Charles T.
- Abstract
We recently reported that spironolactone and eplerenone, mineralocorticoid receptor (MR) antagonists, markedly reduced proteinuria and vascular injury in saline-drinking stroke-prone spontaneously hypertensive rats (SHRSP). Presently, we examined whether amiloride (AMIL), a highly effective sodium channel blocker, would mimic the effect of MR antagonists against the development of pathology in these rats. Saline-drinking SHRSP were either untreated (control, n=7) or given AMIL (1 mg/Kg/day in the drinking solution, n=8) starting at 8.5 weeks of age. Six of seven control SHRSP showed signs of stroke with 71 % mortality at 13 weeks of age. All of the eight AMIL-treated SHRSP continued to gain body weight and showed no signs of stroke through 14.6 weeks of age. Urinary protein excretion was 101 ± 23 v 18 ± 1 mg/day, respectively, in the control and AMIL groups (P<0.002) at 11.6 weeks of age. Systolic blood pressure was 228±6 and 217±3 mmHg, respectively, in the control and AMIL groups at this time (P>0.1). Hematocrit was significantly lowered in control (45.7 ± 1.5 %) v AMIL-treated (53.5 ± 0.8 %) SHRSP (P<0.002) which is consistent with the development of thrombotic microangiopathic injury in the former group. The urinary sodium to potassium concentration ratio averaged 4.7 in these saline-drinking animals and was not increased by AMIL treatment. These findings implicate a role for sodium channels in the evolution of vascular injury in saline-drinking SHRSP. Whether this involves a renal or extrarenal effect requires further investigation.Am J Hypertens (2001) 14, 2A-2A; doi:S0895-7061(01)01321-8
- Publication
American Journal of Hypertension, 2001, Vol 14, p2A
- ISSN
0895-7061
- Publication type
Article
- DOI
10.1016/S0895-7061(01)01321-8